Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11(6):718–26.

Article  PubMed  Google Scholar 

Tuligenga RH, Dugravot A, Tabák AG, Elbaz A, Brunner EJ, Kivimäki M, et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014;2(3):228–35.

Article  PubMed  PubMed Central  Google Scholar 

Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604.

Article  PubMed  PubMed Central  Google Scholar 

Dove A, Shang Y, Xu W, Grande G, Laukka EJ, Fratiglioni L, et al. The impact of diabetes on cognitive impairment and its progression to dementia. Alzheimers Dement. 2021;17(11):1769–78.

Article  PubMed  Google Scholar 

Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and cognitive impairment. Curr Diab Rep. 2016;16(9):87.

Article  PubMed  PubMed Central  Google Scholar 

Weinstein G, Davis-Plourde KL, Conner S, Himali JJ, Beiser AS, Lee A, et al. Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: pooled analysis from 5 cohorts. PLoS ONE. 2019;14(2):e0212293.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29–38.

Article  PubMed  Google Scholar 

Cukierman-Yaffe T, Bosch J, Diaz R, Dyal L, Hancu N, Hildebrandt P, et al. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial. Lancet Diabetes Endocrinol. 2014;2(7):562–72.

Article  CAS  PubMed  Google Scholar 

Tuligenga RH. Intensive glycaemic control and cognitive decline in patients with type 2 diabetes: a meta-analysis. Endocr Connect. 2015;4(2):R16–24.

Article  PubMed  PubMed Central  Google Scholar 

Bahadar GA, Shah ZA. Intracerebral hemorrhage and diabetes mellitus: blood-brain barrier disruption, pathophysiology and cognitive impairments. CNS Neurol Disord: Drug Targets. 2021;20(4):312–26.

Article  CAS  PubMed  Google Scholar 

Brook E, Mamo J, Wong R, Al-Salami H, Falasca M, Lam V, et al. Blood-brain barrier disturbances in diabetes-associated dementia: therapeutic potential for cannabinoids. Pharmacol Res. 2019;141:291–7.

Article  CAS  PubMed  Google Scholar 

Rom S, Zuluaga-Ramirez V, Gajghate S, Seliga A, Winfield M, Heldt NA, et al. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol. 2019;56(3):1883–96.

Article  CAS  PubMed  Google Scholar 

Lin L, Wu Y, Chen Z, Huang L, Wang L, Liu L. Severe hypoglycemia contributing to cognitive dysfunction in diabetic mice is associated with pericyte and blood-brain barrier dysfunction. Front Aging Neurosci. 2021;13:775244.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Jiao F, Border JJ, Fang X, Crumpler RF, Liu Y, et al. Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals. Am J Physiol Heart Circ Physiol. 2022;322(2):H246–59.

Article  CAS  PubMed  Google Scholar 

Ward R, Li W, Abdul Y, Jackson L, Dong G, Jamil S, et al. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res. 2019;142:237–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135(3):311–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mäe MA, He L, Nordling S, Vazquez-Liebanas E, Nahar K, Jung B, et al. Single-cell analysis of blood-brain barrier response to pericyte loss. Circ Res. 2021;128(4):e46–62.

Article  PubMed  Google Scholar 

Jeong HW, Diéguez-Hurtado R, Arf H, Song J, Park H, Kruse K, et al. Single-cell transcriptomics reveals functionally specialized vascular endothelium in brain. eLife. 2022;11.

Xiao L, do Carmo LS, Foss JD, Chen W, Harrison DG. Sympathetic enhancement of memory T-cell homing and hypertension sensitization. Circul Res. 2020;126(6):708–21.

Wang J, Xu J, Zang G, Zhang T, Wu Q, Zhang H, et al. Trans-2-enoyl-CoA reductase tecr-driven lipid metabolism in endothelial cells protects against transcytosis to maintain blood-brain barrier homeostasis. Research. 2022;2022:9839368.

CAS  PubMed  PubMed Central  Google Scholar 

Ahire C, Nyul-Toth A, DelFavero J, Gulej R, Faakye JA, Tarantini S, et al. Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain. Aging Cell. 2023;22(7):e13832.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vanlandewijck M, He L, Mäe MA, Andrae J, Ando K, Del Gaudio F, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554(7693):475–80.

Article  CAS  PubMed  Google Scholar 

He S, Sharpless NE. Senescence in health and disease. Cell. 2017;169(6):1000–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamazaki Y, Baker DJ, Tachibana M, Liu CC, van Deursen JM, Brott TG, et al. Vascular cell senescence contributes to blood-brain barrier breakdown. Stroke. 2016;47(4):1068–77.

Article  PubMed  PubMed Central  Google Scholar 

Ya J, Kadir RRA, Bayraktutan U. Delay of endothelial cell senescence protects cerebral barrier against age-related dysfunction: role of senolytics and senomorphics. Tissue Barriers. 2023;11(3):2103353.

Article  PubMed  Google Scholar 

Salvador E, Burek M, Löhr M, Nagai M, Hagemann C, Förster CY. Senescence and associated blood-brain barrier alterations in vitro. Histochem Cell Biol. 2021;156(3):283–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Phoenix A, Chandran R, Ergul A. Cerebral microvascular senescence and inflammation in diabetes. Front Physiol. 2022;13:864758.

Article  PubMed  PubMed Central  Google Scholar 

Bury JJ, Chambers A, Heath PR, Ince PG, Shaw PJ, Matthews FE, et al. Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain. Acta Neuropathol Commun. 2021;9(1):5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Lin W, Sun Y, Wang Q, He S, Han Z, et al. Quercetin targets VCAM1 to prevent diabetic cerebrovascular endothelial cell injury. Front Aging Neurosci. 2022;14:944195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi J, Yin Q, Zhang L, Wu Y, Yi P, Guo M, et al. Zi Shen Wan Fang attenuates neuroinflammation and cognitive function via remodeling the gut microbiota in diabetes-induced cognitive impairment mice. Front Pharmacol. 2022;13:898360.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin Q, Zhang L, Han X, Zhang H, Wang F, Qin X, et al. Zi Shen Wan Fang regulates kynurenine metabolism to alleviate diabetes-associated cognitive impairment via activating the skeletal muscle PGC1α-PPARα signaling. Phytomedicine. 2022;99:154000.

Article  CAS